Definitive Healthcare Corp. logo DH - Definitive Healthcare Corp.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 3
HOLD 9
SELL 3
STRONG
SELL 0
| PRICE TARGET: $1.20 DETAILS
HIGH: $1.50
LOW: $1.00
MEDIAN: $1.10
CONSENSUS: $1.20
UPSIDE: 22.62%

Stock News

Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison

Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison

Definitive Healthcare (NASDAQ: DH - Get Free Report) and Firefly Neuroscience (NASDAQ: AIFF - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Profitability This table compares Definitive Healthcare and

Oct 04, 2026 12:14 PM • defenseworld.net
Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)

Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)

HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Earnings and Valuation This table compares HealthStream and

Sep 07, 2026 11:59 PM • defenseworld.net
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company's Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests of AIDH TopCo, LLC (the “Definitive OpCo Units”), in each case, that are not already owned by Advent or Jason Krantz, the Company's founder and Executive Chairman, for an all-cash purchase price of $1.02 per share of Class A common stock, and an equivalent amount per Definitive OpCo Unit.

Sep 02, 2026 05:15 AM • globenewswire.com
Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison

Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison

Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation. Insider and Institutional Ownership 98.7% of Definitive Healthcare

Sep 01, 2026 09:46 PM • defenseworld.net
Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast

Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its second quarter ended June 30, 2026, on Monday, August 10, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Aug 03, 2026 12:05 PM • globenewswire.com
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Srinivas Attipalli of the Company, Definitive Healthcare's new SVP and Head of AI & Data - Product, an inducement award consisting of 1,063,830 time-based restricted stock units (“RSUs”), effective July 24, 2026. These awards were individually negotiated and granted as an inducement material to Mr. Attipalli's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

Jul 27, 2026 12:05 PM • globenewswire.com
Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

Latest enhancements provide deeper medical claims insights, a new integration with HubSpot®, seamless access to healthcare professional (HCP) data directly in Salesforce, and AI search capabilities Latest enhancements provide deeper medical claims insights, a new integration with HubSpot®, seamless access to healthcare professional (HCP) data directly in Salesforce, and AI search capabilities

May 21, 2026 05:05 AM • globenewswire.com

Price Targets